跳至主要内容

Method for Checking the Water Content in the Development of Solid Dosage Forms

 Medicines are the foundation for human survival and social development, and are related to people’s lives, health and safety. In the research and development of solid dosage forms, some drugs need to be treated with water, and some need to be added with a certain amount of liquid excipients. Improper operation will affect the quality and hardness of the preparations. At the same time, there are certain safety hazards. Therefore, check the contents of the pharmaceutical preparations. The moisture content is critical. In order to remove the water in the preparation, some companies have spent a lot of thought and price, but in exchange it is the result of the product’s quality guarantee for at most several months.

Since the water content of the drug may affect the stability, physical and chemical properties, and physiological effects of the drug preparation, the quality standards in the development of most APIs and solid preparations require a water check item. Medicilon provides new drug research and development outsourcing services. It has the preparation process and quality research of tablets, injections, capsules, granules, ointments, creams, sprays, gels, syrups, tinctures, oral liquid preparations, etc. Commonly used equipment and instruments, as well as the GMP pilot plant for oral solid preparations, it also has the ability to develop new technologies such as sustained and controlled release preparations, nano preparations, and fat emulsions.

Medicilon provides R&D and production services for pharmaceutical preparations. According to the characteristics of the dosage form, combined with the physical and chemical properties and stability of the drug, the production conditions and equipment are considered, process research is carried out, the preparation process of laboratory samples is initially determined, and the corresponding Process control indicators.

Solid Dosage Forms

The commonly used methods for determining the moisture content of drugs are mainly as follows.

Karl Fischer titration

The water content is determined based on the principle that iodine and sulfur dioxide react quantitatively with water in pyridine and methanol solutions. This method can be applied to any drug that can be dissolved in the Fischer test solution but does not react chemically with the Fischer test solution. Therefore, this method can still be used for the determination of samples that are easily damaged by heat. When measuring, first dissolve the sample in the prescribed solvent and then titrate. Normally, all the water in the sample is released into the solvent, so the measurement result includes two parts: adsorbed water and bound water.

However, it should be noted that some oxidants such as chromate, reducing agents such as thiosulfate and other compounds that can form water with the test solution will interfere with the determination; some carbonyl compounds also interfere with this method: active aldehydes and ketones and reagents Methanol reacts to form acetal and water, causing the test result to be high. 

Determination of loss on drying

The loss on drying of a drug refers to the percentage of weight loss of the drug after drying under specified conditions. It mainly refers to moisture, crystal water and other volatile substances. The loss on drying of the test product is calculated from the weight loss and the sample amount. The loss-on-drying method measures the weight loss of a sample after drying under normal pressure or reduced pressure. The loss is mainly moisture except for a very small amount of organic solvent.

This method can accurately determine the moisture content of most drugs, but when the sample contains crystal water, especially when the crystal water is closely bound to the drug molecules, the result of the determination is often not the total amount of water in the sample, but only adsorbed water.

Medicilon Formulation Services
Medicilon Formulation Services

Thermogravimetric analysis method(TGA)

Thermogravimetry, also known as thermogravimetry, is a technique for measuring the relationship between the weight of a substance and the temperature under program-controlled temperature. Under normal circumstances, this method is suitable for the determination of drug crystal water and the analysis of weight loss on drying of precious drugs (with a small sample amount) or drugs that are easily oxidized in the air. Like the loss-on-drying method, this method also uses heating to make the sample weightless, but uses a program to control the temperature. The advantage is that the amount of sample required for the measurement is smaller, the analysis time is shorter, the data processing is more convenient, and the amount of information obtained is large. . However, when the crystal water and the drug molecule are very tightly bound, the crystal water is released when the drug melts and decomposes. The measurement result at this time is likely to cause the illusion that there is no crystal water in the sample.

Differential scanning calorimetry

This method is a technique to measure the relationship between the energy difference and temperature (or time) between the substance to be measured and the reference substance under the program control temperature. When the sample contains crystal water, there will usually be obvious absorption in the spectrum. Hot peak. However, when the crystal water is tightly bound to the sample molecules, the endothermic peak of the crystal water may overlap with the melting endothermic peak of the sample.

Formulation services
Formulation Services in Medicilon

Single crystal X-ray diffraction method

It is possible to accurately determine whether crystal water is bound in the sample under this crystal form and the way of binding, but the disadvantage is that the preparation of single crystals is difficult, time-consuming, and sometimes even unable to obtain single crystals, so this method has certain limitations.

In summary, it is recommended that the following principles should be followed when choosing a conventional moisture determination method:

(1) When the sample is easily soluble in methanol or pyridine and does not interfere with the titration, the Fischer method is preferred;

(2) If the Fisher method is not suitable for measuring the moisture of the species under the conventional test conditions, the loss on drying method can be considered, but in the methodological research, it is recommended to use the Fisher method, thermogravimetric analysis method, and differential scanning volume. Thermal method, combined with literature reports for comprehensive analysis and verification;

(3) For drugs with new structures, single crystal X-ray analysis is recommended to confirm the binding mode of water in the sample, so as to provide an accurate chemical structure basis for later quality research, stability research and physiological activity research.

Contact Us:

Email : marketing@medicilon.com

Tel : +44 1223 981 792 (Europe)

        +82 (0)70-8269-5849 (South Korea)

        08044216898 (Japan)

        +86 021 58591500 (China)

Website: https://www.medicilon.com

Related Articles:

Analysis on the Composition and Preparation Process of Oral Solid Dosage Forms

Dosage Research and Common Dosage Forms

The Spray Drying Method of Solid Dispersant Preparation Technology

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati